INZY
Inozyme Pharma, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Douglas A. Treco
IPO Date
2020-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Inozyme Pharma, Inc.
CEO
Douglas A. Treco
IPO Date
2020-07-24
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 38,500 |
| $0.00 |
| 3 Jul 2025 | Subramanian Sanjay | SVP, CFO & Head of BD | D-Return | Disposed | 180,000 | $3.96 |
| 3 Jul 2025 | Subramanian Sanjay | SVP, CFO & Head of BD | D-Return | Disposed | 135,000 | $3.30 |
| 3 Jul 2025 | Subramanian Sanjay | SVP, CFO & Head of BD | D-Return | Disposed | 145,000 | $1.06 |
| 3 Jul 2025 | Winton Matthew | COO | U-Tender | Disposed | 21,743 | $4.00 |
| 3 Jul 2025 | Winton Matthew | COO | D-Return | Disposed | 41,500 | $0.00 |
| 3 Jul 2025 | Winton Matthew | COO | D-Return | Disposed | 145,000 | $1.06 |
| 3 Jul 2025 | Bolte Axel | director | U-Tender | Disposed | 423,926 | $4.00 |
| 3 Jul 2025 | Bolte Axel | director | D-Return | Disposed | 234,176 | $2.02 |